Arrowhead Pharmaceuticals

US · ARWR #1569 by market cap Listed 1970

61.48 -0.06 -0.10%

Live - 5344 symbols - heartbeat 223s ago · 2026-10-08 06:51

Pre-market 60.60 -1.43%

After-hours 61.48 0.00%

Overnight 61.48 0.00%

Market cap: 8.68B
P/E (TTM): -26.96
P/B: 18.65
EPS: -0.01
Div yield: 0.00%
52W pos: 44%

Reader sentiment Are you bullish or bearish on ARWR?

Anonymous reader poll. Unscientific, not investment advice.

About Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Founded: 1989
CEO: Dr. Christopher Anzalone,PhD
Employees: 711
Headquarters: Pasadena, California, United States of America
Fiscal year end: 09-30
Website: arrowheadpharma.com

Company profile

Exchange: US
Symbol: ARWR
Market-cap rank: #1569
Listing date: 1970-01-01
Market cap: 8.68B
Float cap: 7.53B
Shares out: 141.25M
Float shares: 122.45M

Sectors & themes

Biotechnology Weight Loss Drugs Global medical industry Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 06:51:28 · For reference only, not investment advice and not tailored to your situation.